SEATTLE, June 17, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global cardiac implants market is estimated to be valued at US$ 35,795.6 Million in 2022 and is expected to exhibit a CAGR of 8.1% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Cardiac Implants Market:
Market players are engaged in rapid research and development activities to develop technologically advanced cardiac implants, which is expected to drive the market growth over the forecast period. For instance, in April 2022, Abiomed, a U.S.-based medical device company announced that the first patient in the world has been successfully implanted with its new Impella Bridge-to-Recovery (BTR) system at Northwestern Medicine Bluhm Cardiovascular Institute, as a part of the U.S. Food and Drug Administration Early Feasibility Study.
Moreover the increasing approval by the regulatory bodies for carrying out research related studies is expected to drive the market. For instance, in January 2022, Abiomed announced that it had received the U.S. FDA approval for Early Feasibility Study. The aim of Impella BTR development study is to provide a chronic heart failure patient with home discharge and up to 1 year of full hemodynamic support. Impella BTR is a forward flow heart pump which is implanted via the axillary artery and stays in the left ventricle. It is smaller in size and less invasive than traditional LVADs (Left ventricular assist device). Impella BTR allows chronic heart failure patients to have a longer-term minimally invasive heart pump option as compared to conventional LVADs.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1176
Key Market Takeaways:
Global cardiac implants market is expected to exhibit a CAGR of 8.1% during the forecast period, owing to launch of new cardiac implants. Cardiac patients prefer non-surgical and minimally invasive options for the treatment of heart conditions such as arrhythmias, heart failure, heart attacks, and others. Medical devices such as wearable cardiac defibrillator, wearable automatic pacemakers, and others may act as substitutes/alternatives to cardiac implants due to the reduced risk of infection and non-invasive nature of these devices. Market players are engaged in obtaining regulatory approvals for wearable cardiac devices. For instance, in July 2021, Kestra Medical Technologies, a U.S.-based wearable medical device company announced that it had received the U.S. FDA approval for its ASSURE Wearable Cardioverter Defibrillator (WCD) System, which is a next generation of monitoring and therapy to protect patients at the risk of sudden cardiac arrest.
Among device type, coronary stents segment is estimated to account large market share in 2022. Increasing focus of market players in research and development activities for developing advanced coronary stents is expected to drive the segment growth over the forecast period. For instance, in July 2020, Sino Medical Sciences Technology Inc., a China-based medical device company announced that it had completed one year follow-up in the PIONEER-III clinical trial of its investigational device called BuMA Supreme Drug-Eluting Coronary Stent (DES). BuMA Supreme DES is an advanced coronary stent which is developed to maximize functional healing of the blood vessels after a stent implantation.
Key players operating in the global cardiac implants market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd. , Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, OSYPKA MEDICAL, Pacetronix.com, Vitatron, Terumo Corporation, Cordis, MicroPort Scientific Corporation.
Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1176
Detailed Segmentation:
Global Cardiac Implants Market, By Device Type
- Pacemaker Devices
- Cardiac Resynchronization Therapy Devices
- Implantable Hemodynamic Monitoring Devices
- Implanted Heart Rhythm Monitors
- Coronary Stents
- Implantable Cardioverter Defibrillator
- Heart Valve
- Others
Global Cardiac Implants Market, By Application
- Arrhythmias
- Myocardial Ischemia
- Acute Myocardial Infraction
- Congestive Heart Failure
- Others
Global Cardiac Implants Market, By End User
- Hospitals
- Specialty Clinics
- Others
Global Cardiac Implants Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- Europe
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- By Country:
- GCC Countries
- Israel
- South Africa
- Rest of Middle East & Africa
Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/1176
Find more related trending reports below:
Cardiac Implantable Electronic Device Market, By Type (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Specialty Clinics, and Ambulatory Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Cardiac Remote Patient Monitoring Device Market, by Application (Cardiac Arrhythmias, Ischemic Diseases, and Hypertension), by End Users (Hospitals, Cardiac Clinics, Ambulatory Surgery Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Cardiac Pacing Leads Market, by Product Type (Unipolar, Bipolar, and Others), by Technology (Transcutaneous Pacing, Trans Venous Pacing, and Epicardial Pacing), by End User (Catheterization Labs, Orthopedic Clinics, Hospitals, and Ambulatory Surgery Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg
